Special Seminar
Monday, August 25, 2025
Hideyuki Okano
Professor, Department of Physiology, Keio University School of Medicine
Hideyuki Okano, MD, PhD, will give a talk entitled “Regenerative Strategies and Disease Modeling Using iPSCs: Focus on Spinal Cord Injury and Neurodegeneration.”
Hosted by Lana Zholudeva.
Details
Audience
Gladstone and UCSFDiversity, Equity, and Inclusion
At Gladstone, we are committed to providing events and professional development activities that resonate with our community’s diverse members. Our goal is to develop creative programming that encompasses a wide variety of ideas and perspectives to inspire, educate, and engage with everyone within our walls.
We want to effect positive change through our events and activities by providing a platform for discussions on important topics related to increasing diversity and inclusiveness in the sciences.
Related News
Pregnancy, Lactation Shape Immune Response to COVID-19 Vaccine and Infection
Study finds strong immune defenses in pregnant and lactating women, with key benefits that could guide future vaccine design.
Inside the Brain: Tackling Neurological Disease at Its Roots
For World Brain Day, discover some of Gladstone’s latest breakthroughs in neurological research.
Combination of Two Cancer Drugs May Work Against Alzheimer’s
A new study has identified FDA-approved cancer drugs that reverse the gene expression signatures associated with Alzheimer’s.
Remembering Bill Rutter, a Biotech Visionary and Champion of Gladstone
William J. Rutter, PhD, was a pioneering force in biomedicine whose vision shaped San Francisco’s Mission Bay neighborhood into a hub for innovation and discovery.
Our San Francisco Location | The Gladstone Difference
Learn how Gladstone's location fosters enriching collaborations and partnerships.
Growing Together: Deepak Srivastava Marks 20 Years at Gladstone
As Deepak Srivastava celebrates two remarkable decades at Gladstone, we revisit key career milestones and look forward to the future he continues to shape.
Ask a Scientist: When Will Immunotherapy Work on Common Cancers?
For Cancer Immunotherapy Month, Karin Pelka answers questions about how immunotherapy can treat patients with solid tumors and the challenges that scientists are working to overcome.
Milestones in the COVID-19 Pandemic
A look back at highlights since 2020.
Culture Is Our Superpower | The Gladstone Difference
Discover how Gladstone fosters an environment in which people are having fun, working hard, and driven to save human lives.
From Chaos to Clarity: New Tool Finds Connections in Complex Cell Data
A powerful computation tool integrates different forms of biological data to reveal how cell types are related across tissues, experiments, and species—information that’s crucial for understanding…
Meet Gladstone: Sarah Nyquist
Sarah Nyquist is a bioinformatics fellow, researching human mammary gland milk production to address the gap in understanding how disease, lifestyle, and genetics impact breast milk.
Science in Seconds | Gladstone Researchers Tackle Charcot-Marie-Tooth (CMT) Disease
Bruce Conklin and his team at Gladstone are tackling Charcot-Marie-Tooth (CMT) disease, the most common inherited neurological disorders—for which there is currently no cure.
Zhaoqi Yan Named a 2025 Warren Alpert Distinguished Scholar
Gladstone researcher receives prize to study blood-brain barrier dysfunction and its impact on neurological disease.
Karin Pelka Wins Grant to Advance Immunotherapy for Colorectal Cancer
The Colorectal Cancer Alliance has awarded Pelka a $500,000 grant to develop novel immunotherapies that overcome the most common form of colorectal cancer.
Ultimate Self-Sacrifice: Bacteria Activate Unusual Defense to Evade Viral Attack
Scientists discover that a well-known defense system in some bacteria can kill the cell as a last resort if viruses try to thwart it.